These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 33330841)

  • 1. Ebselen, Disulfiram, Carmofur, PX-12, Tideglusib, and Shikonin Are Nonspecific Promiscuous SARS-CoV-2 Main Protease Inhibitors.
    Ma C; Hu Y; Townsend JA; Lagarias PI; Marty MT; Kolocouris A; Wang J
    ACS Pharmacol Transl Sci; 2020 Dec; 3(6):1265-1277. PubMed ID: 33330841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ebselen, disulfiram, carmofur, PX-12, tideglusib, and shikonin are non-specific promiscuous SARS-CoV-2 main protease inhibitors.
    Ma C; Hu Y; Townsend JA; Lagarias PI; Marty MT; Kolocouris A; Wang J
    bioRxiv; 2020 Sep; ():. PubMed ID: 32995786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation and invalidation of SARS-CoV-2 main protease inhibitors using the Flip-GFP and Protease-Glo luciferase assays.
    Ma C; Tan H; Choza J; Wang Y; Wang J
    Acta Pharm Sin B; 2022 Apr; 12(4):1636-1651. PubMed ID: 34745850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invalidation of dieckol and 1,2,3,4,6-pentagalloylglucose (PGG) as SARS-CoV-2 main protease inhibitors and the discovery of PGG as a papain-like protease inhibitor.
    Tan H; Ma C; Wang J
    Med Chem Res; 2022; 31(7):1147-1153. PubMed ID: 35578732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invalidation of dieckol and 1,2,3,4,6-pentagalloylglucose (PGG) as SARS-CoV-2 main protease inhibitors and the discovery of PGG as a papain-like protease inhibitor.
    Tan H; Ma C; Wang J
    Res Sq; 2022 Mar; ():. PubMed ID: 35378761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Essential Role of Enterovirus 2A Protease in Counteracting Stress Granule Formation and the Induction of Type I Interferon.
    Visser LJ; Langereis MA; Rabouw HH; Wahedi M; Muntjewerff EM; de Groot RJ; van Kuppeveld FJM
    J Virol; 2019 May; 93(10):. PubMed ID: 30867299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validating Enterovirus D68-2A
    Musharrafieh R; Ma C; Zhang J; Hu Y; Diesing JM; Marty MT; Wang J
    J Virol; 2019 Apr; 93(7):. PubMed ID: 30674624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation and Invalidation of SARS-CoV-2 Papain-like Protease Inhibitors.
    Ma C; Wang J
    ACS Pharmacol Transl Sci; 2022 Feb; 5(2):102-109. PubMed ID: 35178512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the efficacy of HIV protease inhibitors against SARS-CoV-2's main protease.
    Mahdi M; Mótyán JA; Szojka ZI; Golda M; Miczi M; Tőzsér J
    Virol J; 2020 Nov; 17(1):190. PubMed ID: 33243253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral Potential of a Novel Compound CW-33 against Enterovirus A71 via Inhibition of Viral 2A Protease.
    Wang CY; Huang AC; Hour MJ; Huang SH; Kung SH; Chen CH; Chen IC; Chang YS; Lien JC; Lin CW
    Viruses; 2015 Jun; 7(6):3155-71. PubMed ID: 26090728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2-Pyridone natural products as inhibitors of SARS-CoV-2 main protease.
    Forrestall KL; Burley DE; Cash MK; Pottie IR; Darvesh S
    Chem Biol Interact; 2021 Feb; 335():109348. PubMed ID: 33278462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the Dimerization of the Main Protease of Coronaviruses: A Potential Broad-Spectrum Therapeutic Strategy.
    Goyal B; Goyal D
    ACS Comb Sci; 2020 Jun; 22(6):297-305. PubMed ID: 32402186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease.
    Ma C; Sacco MD; Hurst B; Townsend JA; Hu Y; Szeto T; Zhang X; Tarbet B; Marty MT; Chen Y; Wang J
    bioRxiv; 2020 Jan; ():. PubMed ID: 32511378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a Cell-Based Luciferase Complementation Assay for Identification of SARS-CoV-2 3CL
    Rawson JMO; Duchon A; Nikolaitchik OA; Pathak VK; Hu WS
    Viruses; 2021 Jan; 13(2):. PubMed ID: 33498923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for substrate binding-induced zwitterion formation in the catalytic Cys-His dyad of the SARS-CoV main protease.
    Paasche A; Zipper A; Schäfer S; Ziebuhr J; Schirmeister T; Engels B
    Biochemistry; 2014 Sep; 53(37):5930-46. PubMed ID: 25196915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reckoning a fungal metabolite, Pyranonigrin A as a potential Main protease (M
    Rao P; Shukla A; Parmar P; Rawal RM; Patel B; Saraf M; Goswami D
    Biophys Chem; 2020 Sep; 264():106425. PubMed ID: 32663708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a Fluorescence-Based, High-Throughput SARS-CoV-2 3CL
    Froggatt HM; Heaton BE; Heaton NS
    J Virol; 2020 Oct; 94(22):. PubMed ID: 32843534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization Rules for SARS-CoV-2 M
    Stoddard SV; Stoddard SD; Oelkers BK; Fitts K; Whalum K; Whalum K; Hemphill AD; Manikonda J; Martinez LM; Riley EG; Roof CM; Sarwar N; Thomas DM; Ulmer E; Wallace FE; Pandey P; Roy S
    Viruses; 2020 Aug; 12(9):. PubMed ID: 32859008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic Inhibition of SARS-CoV-2 Replication Using Disulfiram/Ebselen and Remdesivir.
    Chen T; Fei CY; Chen YP; Sargsyan K; Chang CP; Yuan HS; Lim C
    ACS Pharmacol Transl Sci; 2021 Apr; 4(2):898-907. PubMed ID: 33855277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High Throughput Virtual Screening to Discover Inhibitors of the Main Protease of the Coronavirus SARS-CoV-2.
    Olubiyi OO; Olagunju M; Keutmann M; Loschwitz J; Strodel B
    Molecules; 2020 Jul; 25(14):. PubMed ID: 32668701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.